LXRs are NRs that have been shown to promote cancer cell death through the effect of their ligands in preclinical studies of various cancers, partly due to reduced activity of the PI3K/Akt/mTOR pathway [9, 23, 24]. The gene discussed is MTOR; the disease is cancer.